News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
69 Results
Type
Article (3)
Press Release (66)
Section
Business (18)
Deals (1)
Drug Development (1)
FDA (4)
News (25)
Policy (1)
Tag
Alliances (5)
Alzheimer's disease (1)
Approvals (4)
Clinical research (1)
Depression (1)
Earnings (5)
Events (5)
FDA (4)
Healthcare (2)
IPO (1)
Medical device (10)
Medtech (10)
Neuroscience (2)
People (10)
Phase III (1)
Pipeline (1)
Regulatory (1)
United States (1)
Date
Last 365 days (3)
2025 (1)
2024 (2)
2023 (2)
2022 (7)
2021 (4)
2018 (3)
2017 (26)
2015 (3)
2014 (9)
2013 (1)
2012 (3)
2011 (2)
2010 (1)
Location
Asia (1)
Australia (1)
Europe (51)
Massachusetts (1)
69 Results for "nexstim".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nexstim Receives Order for NBS System 5 in Finland
September 27, 2024
·
2 min read
Press Releases
Nexstim PLC Half-Year Report January 1 – June 30, 2024 (Unaudited)
August 16, 2024
·
17 min read
Nexstim Receives an Order for Two NBT® Systems from Canada
Nexstim Plc announces that it has received an order for two NBT® systems through Canadian Health Solutions, the Company’s distributor in Canada.
December 14, 2022
·
4 min read
Nexstim NBS 5+ System Continues to Generate Interest in the US
Nexstim Plc announces that Drs. Lauren Marangell and Rayan Al Jurdi, experts in the treatment of major depression, have purchased a NBS 5+ system.
October 6, 2022
·
2 min read
Nexstim Receives an NBS 5+ System Order from Seattle Children’s Hospital
Nexstim Plc announced it has received an NBS 5+ system order from Seattle Children’s in the United States.
June 2, 2022
·
2 min read
Nexstim Releases the New NBS5+ in the United States
Nexstim Plc announces the launch of a new navigated transcranial magnetic stimulation system configuration in the United States, to further strengthen competitive advantage in this market.
October 22, 2021
·
2 min read
Nexstim Plc to license technology to US-based medical technology company Magnus Medical, Inc. for the treatment of neuropsychiatric disorders
Nexstim Plc announces it has signed an agreement to license technology it has developed to Magnus Medical, Inc., a US-based medical technology company.
February 14, 2022
·
7 min read
Nexstim Extends Agreement with Canadian Distributor and Receives Order for Three NBT® Systems
Nexstim Plc announces that it has extended its agreement with Canadian Health Solutions group, the Company’s distributor in Canada, for an additional five years.
May 25, 2021
·
2 min read
Press Releases
Sinaptica Announces Initiation of Co-Development of the SinaptiStim® Precision Neuromodulation System to treat Alzheimer’s Disease; On Track for Pivotal Clinical Trial Initiation in 2025
January 15, 2025
·
7 min read
Nexstim’s Financial Information in 2018
Nexstim’s Annual Report 2017 will be published on the Company’s website on Wednesday, March 7, 2018.
December 13, 2017
·
2 min read
1 of 7
Next
